X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1276) 1276
Publication (47) 47
Patent (34) 34
Book Chapter (2) 2
Conference Proceeding (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (639) 639
female (458) 458
male (453) 453
cardiac & cardiovascular systems (444) 444
index medicus (412) 412
aged (393) 393
middle aged (374) 374
stents (324) 324
treatment outcome (270) 270
cardiovascular (209) 209
stent (201) 201
risk factors (192) 192
percutaneous coronary intervention (174) 174
coronary angiography (172) 172
mortality (172) 172
restenosis (169) 169
drug-eluting stents (163) 163
angioplasty (162) 162
thrombosis (152) 152
heart attacks (151) 151
care and treatment (136) 136
time factors (125) 125
internal medicine (123) 123
cardiac patients (120) 120
abridged index medicus (117) 117
cardiology (117) 117
implantation (113) 113
follow-up studies (110) 110
coronary heart disease (109) 109
myocardial infarction (108) 108
cardiology and cardiovascular medicine (107) 107
angioplasty, balloon, coronary (106) 106
analysis (105) 105
peripheral vascular disease (103) 103
transluminal angioplasty (103) 103
coronary artery disease (102) 102
risk (102) 102
myocardial infarction - therapy (98) 98
ticlopidine - analogs & derivatives (94) 94
coronary vessels (93) 93
prognosis (93) 93
clopidogrel (91) 91
drug-eluting stent (84) 84
platelet aggregation inhibitors - therapeutic use (84) 84
hematology (81) 81
drug therapy (77) 77
heart attack (77) 77
bare-metal stents (76) 76
coronary artery disease - therapy (75) 75
prospective studies (75) 75
cardiovascular disease (72) 72
randomized controlled trials as topic (71) 71
medicine, general & internal (70) 70
myocardial-infarction (69) 69
metaanalysis (68) 68
sirolimus - administration & dosage (67) 67
risk assessment (66) 66
outcomes (65) 65
percutaneous coronary intervention - adverse effects (65) 65
myocardial infarction - mortality (64) 64
kaplan-meier estimate (63) 63
proportional hazards models (62) 62
recurrence (62) 62
artery-disease (61) 61
balloon angioplasty (60) 60
coronary artery disease - mortality (60) 60
coronary disease - therapy (60) 60
clinical trials (59) 59
coronary restenosis - prevention & control (59) 59
diabetes (57) 57
intervention (57) 57
platelet aggregation inhibitors - administration & dosage (57) 57
acute myocardial-infarction (56) 56
multivariate analysis (56) 56
prosthesis design (56) 56
studies (56) 56
abciximab (55) 55
acute coronary syndromes (55) 55
follow-up (55) 55
trial (55) 55
predictive value of tests (53) 53
aged, 80 and over (52) 52
retrospective studies (51) 51
randomized-trial (50) 50
stent thrombosis (50) 50
survival analysis (50) 50
ticlopidine - administration & dosage (50) 50
ticlopidine - therapeutic use (50) 50
revascularization (49) 49
disease (48) 48
therapy (48) 48
sirolimus (47) 47
myocardial infarction - etiology (46) 46
patients (46) 46
aspirin (45) 45
electrocardiography (45) 45
genotype (45) 45
research (44) 44
angiography (43) 43
health aspects (43) 43
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1255) 1255
Spanish (33) 33
German (23) 23
French (22) 22
Polish (9) 9
Italian (3) 3
Portuguese (3) 3
Russian (2) 2
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10018, pp. 537 - 544
Summary Background Bioresorbable coronary stents might improve outcomes of patients treated with percutaneous coronary interventions. The everolimus-eluting... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | SYSTEMATIC REVIEWS | RATIONALE | PERFORMANCE | Drug-Eluting Stents | Humans | Middle Aged | Graft Occlusion, Vascular - prevention & control | Myocardial Revascularization - methods | Male | Treatment Outcome | Everolimus - administration & dosage | Myocardial Ischemia - drug therapy | Absorbable Implants | Randomized Controlled Trials as Topic | Tissue Scaffolds | Percutaneous Coronary Intervention - instrumentation | Graft Occlusion, Vascular - etiology | Percutaneous Coronary Intervention - methods | Reoperation - statistics & numerical data | Female | Aged | Myocardial Infarction - prevention & control | Myocardial Infarction - etiology | Myocardial Revascularization - instrumentation | Immunosuppressive Agents - administration & dosage | Angiogenesis inhibitors | Analysis | Cardiac patients | Stent (Surgery) | Cardiovascular agents | Transluminal angioplasty | Heart | Medical research | Medicine, Experimental | Heart diseases | Thrombosis | Blood clot | Studies | Heart attacks | Cardiovascular disease | Acute coronary syndromes | Stents | Clinical outcomes | Meta-analysis | Myocardial infarction | Surgical implants | Websites | Funding | Bias | Clinical trials | Risk | Biomedical materials | Randomization | Ischemia | Implants | Biocompatibility | Safety | Lesions | Thromboembolism | Statistical analysis | Mortality | Blood vessels | Implantation | Coronary artery disease | Death | Diabetes | Cardiovascular diseases | Scaffolds
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 09/2019, Volume 12, Issue 17, pp. 1661 - 1664
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 20, pp. 2060 - 2066
Objectives This study sought to evaluate whether prasugrel may serve as an alternative to clopidogrel in patients with triple therapy. Background Approximately... 
Cardiovascular | Internal Medicine | clopidogrel | aspirin | prasugrel | high platelet reactivity | vitamin K antagonist | drug-eluting stent(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | BLEEDING RISK | DOSE CLOPIDOGREL | EUROPEAN-SOCIETY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | ATRIAL-FIBRILLATION | ANTITHROMBOTIC MANAGEMENT | PERCUTANEOUS CORONARY INTERVENTION | TASK-FORCE | Piperazines - administration & dosage | Prasugrel Hydrochloride | Drug-Eluting Stents | Purinergic P2Y Receptor Antagonists - administration & dosage | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Patient Selection | Vitamin K - antagonists & inhibitors | Myocardial Ischemia - etiology | Platelet Aggregation Inhibitors - administration & dosage | Myocardial Ischemia - therapy | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Aged | Myocardial Ischemia - mortality | Drug Therapy, Combination | Percutaneous Coronary Intervention | Cohort Studies | Aspirin | Anticoagulants (Medicine) | Stent (Surgery) | Adenosine triphosphatase | Studies | Confidence intervals | Heart attacks | Blood platelets | Mortality | Population | Drug therapy | Acute coronary syndromes | Thrombosis | Drug dosages
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 10, pp. 849 - 856
Objectives The aim of this prospective trial was to assess whether platelet reactivity to clopidogrel assessed with multiple electrode platelet aggregometry... 
Cardiovascular | Internal Medicine | clopidogrel | whole blood aggregometry | stent thrombosis | platelet aggregation | ADVERSE CARDIOVASCULAR EVENTS | PERCUTANEOUS CORONARY INTERVENTION | RESPONSIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | IMPLANTATION | PREDICTORS | RESISTANCE | BARE-METAL | ANTAGONISTS | AGGREGOMETRY | Prospective Studies | Platelet Function Tests - methods | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Thrombosis - epidemiology | Coronary Artery Disease - mortality | Electric Impedance | Ticlopidine - analogs & derivatives | Drug-Eluting Stents - adverse effects | Electrodes | Coronary Artery Disease - therapy | Point-of-Care Systems | Thrombosis - etiology | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Function Tests - instrumentation | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Coenzymes | Vasodilators | Adenosine diphosphate | Coronary heart disease | Thrombosis | Stent (Surgery) | Blood clot | Aggregation | Disease transmission | Blood platelets | Analysis | Adenosine triphosphatase | Drug therapy | Intervention | Anticoagulants | Aspirin | Heart attacks | Medical imaging | Cardiovascular disease | Studies | Confidence intervals | Coronary vessels | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9865, pp. 461 - 467
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2016, Volume 67, Issue 8, p. 932
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 8, pp. 932 - 935
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9591, pp. 937 - 948
Journal Article
BMJ (Online), ISSN 0959-8146, 03/2015, Volume 350
Journal Article